NSERC CREATE Program in Microfluidic Applications and Training in Cardiovascular Health

微流体技术被比作微电子技术，因为它有可能影响我们的生活方式。也许这场技术革命最大的科学，社会和经济影响将是其应用于发现和开发新的疗法来预防和治疗心血管疾病，这是加拿大死亡的主要原因和疾病的最大经济负担。主要的生物技术、制药、生命科学和合成化学公司都将化学和生物微系统视为其数十亿美元产业的关键技术，并准备广泛采用。为了实现预期的增长和创新，学术界和工业界之间的研究合作以及在微流体技术和相关生物医学，生物分析和材料合成研究方面拥有跨学科技能的工程师和科学家的需求前所未有。

Microfluidics has been compared to microelectronics in its potential to influence the way we live our lives. Perhaps the greatest scientific, social, and economic impact of this technological revolution will be its application to the discovery and development of novel therapies to prevent and treat cardiovascular disease, the leading cause of death and greatest economic burden of illness in Canada. Chief biotechnology, pharmaceutical, life science, and synthetic chemistry companies all see chemical and biological microsystems as key enabling technologies for their multi-billion dollar industries and are readying themselves for their widespread adoption. To achieve the anticipated growth and innovation, there is unprecedented demand for research collaboration between academia and industry and for engineers and scientists who possess interdisciplinary skills in microfluidic technologies and related biomedical, bioanalytical, and materials synthesis research.